Detalhe da pesquisa
1.
Clinical Factors Associated With 30-Day Mortality Among Patients Undergoing Radiation Therapy for Brain Metastases.
Adv Radiat Oncol
; 8(4): 101211, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37152484
2.
Intracranial and Extracranial Progression and Their Correlation With Overall Survival After Stereotactic Radiosurgery in a Multi-institutional Cohort With Brain Metastases.
JAMA Netw Open
; 6(4): e2310117, 2023 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37099292
3.
Systemic Therapy Type and Timing Effects on Radiation Necrosis Risk in HER2+ Breast Cancer Brain Metastases Patients Treated With Stereotactic Radiosurgery.
Front Oncol
; 12: 854364, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35669439
4.
Prognostic Model for Intracranial Progression after Stereotactic Radiosurgery: A Multicenter Validation Study.
Cancers (Basel)
; 14(21)2022 Oct 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36358606
5.
Application of TG-218 action limits to SRS and SBRT pre-treatment patient specific QA.
J Radiosurg SBRT
; 7(2): 135-147, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33282467
6.
Comprehensive radiation and imaging isocenter verification using NIPAM kV-CBCT dosimetry.
Med Phys
; 47(3): 927-936, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31899806